Millstone Medical Outsourcing, LLC has officially settled into its new, bigger digs. The company is announcing that the it has successfully completed the move of its Memphis operations to a new facility located in Olive Branch, Mississippi, a suburb of Memphis, Tennessee. As of January 7, Millstone Medical was fully operational in the new facility after a complex two-stage moving approach that required validation of equipment and processes and approval from close to 35 customers.
Millstone Medical Now Officially Relocated
1 min read Premium comments
Secondary
The new facility offers 150, 000 square feet of operational space, more than three times the size of the previous facility, for mechanical inspection, world-class loaner kit processing, bone/tissue storage, innovative packaging services, and distribution. Millstone, outsource partner to the nation’s top orthopedic companies, is the fast-growing provider of advanced inspection, clean room packaging, loaner kit processing, and distribution services to medical and dental device manufacturers worldwide.
The new facility also provides high-speed data lines for the company’s enterprise resource planning (ERP) system; new equipment, including high speed autoclaves, freezers, back-up generators, and racking for storage; and enhanced security systems. The benefits of the new facility are expected to be additional space for customer expansion as well as the ability for Millstone to enhance capacity, add new capabilities, and offer greater flexibility.
“With professionals from both the Memphis and Fall River locations working round the clock and over weekends, Millstone was able to finish the complicated move without disruption within three days, ” said Karl Neuberger, Vice President of Memphis Operations of Millstone Medical Outsourcing, in the January 17, 2013 news release. “The additional operational space allows Millstone to expand programs for existing customers and to bring on new customers. We are tremendously excited about all the possibilities the new facility will deliver for the company and our customers.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.